发明名称 MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE
摘要 The present invention provides double-stranded RNA molecules that mediate RNA interference in target cells, preferably hepatic cells. The invention also provides double-stranded RNA (dsRNA) molecules that are modified to be resistant to nuclease degradation, which inactivates a virus, and more specifically, hepatitis C virus (HCV). The invention also provides a method of using these modified RNA molecules to inactivate virus in mammalian cells and a method of making modified small interfering RNAs (siRNAs) using human Dicer. The invention provides modified RNA molecules that are modified to include a dsRNA or siRNA wherein one or more of the pyrimidines in the RNA molecule are modified to include 2′-Fluorine. The invention also provides dsRNA or siRNA in which all pyrimidines are modified to include a 2′-Fluorine. The invention provides that the 2′-Fluorine dsRNA or siRNA molecule is further modified to include a two base deoxynucleotide “TT” sequence at the 3′ end of the molecule.
申请公布号 US2015361432(A1) 申请公布日期 2015.12.17
申请号 US201514819606 申请日期 2015.08.06
申请人 Arrowhead Research Corporation 发明人 Han Jang;Seo Mi-Young;Houghton Michael
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项 1. A method for inactivating Hepatitis C Virus (HCV) in a patient, the method comprising the step of administering to said patient a siRNA in an amount effective to inactivate said virus, wherein said siRNA comprises a first strand and a second strand, wherein the sequence of said first strand is SEQ ID NO: 46 and the sequence of said second strand is selected from the group of SEQ ID NO: 18 and SEQ ID NO: 45.
地址 Pasadena CA US